Cancer Antigen 15.3 (CA 15.3) Test

The CA 15.3 test (cancer antigen 15-3 test) measures the level of a protein called cancer antigen 15-3 in the blood. This protein, also known as MUC-1, is produced by normal breast cells, but many people with breast cancer produce it in larger amounts. For this reason, CA 15-3 is widely used as a tumour marker, a substance whose level in the blood can reflect the presence and activity of a cancer.

It is important to understand what CA 15-3 does and does not do. The antigen itself does not cause cancer; it is released by tumour cells into the bloodstream, particularly as a breast tumour grows or spreads. The CA 15.3 test is mainly used to monitor how well breast cancer treatment is working and to detect a recurrence (return) of cancer after treatment. It is not used as a first screening test to diagnose breast cancer.

CA 15-3 levels are raised in about 80% of women whose breast cancer has spread (metastasised) to other parts of the body, such as the bones or liver, and in fewer women with early-stage disease or small tumours. Because the level can also rise in other cancers and in some non-cancerous conditions, the result is always interpreted alongside a physical examination, other blood tests and imaging.

The CA 15.3 test is mainly used in people already diagnosed with breast cancer, to guide and monitor care. Your doctor may recommend it in the following situations:

• To monitor the response to treatment in women being treated for breast cancer.
• To check for recurrence in women with a history of breast cancer.
• To help assess prognosis and the likelihood of cancer returning.
• To monitor disease activity in metastatic (spread) breast cancer.
• To help guide decisions about which treatment or combination of therapies to use.

This test is primarily relevant for adult women with breast cancer or a history of it, and is ordered by a cancer specialist (oncologist) or gynaecologist. While breast cancer can affect men too, CA 15-3 is used far less often in men. It is not recommended as a routine screening test for people without a breast cancer diagnosis.

As a tumour marker used for monitoring, the CA 15.3 test is repeated over time so that trends - rather than a single value - can be tracked. It is usually repeated every 2 to 3 months during and after treatment, depending on the situation and your doctor's advice.

Women with a history of breast cancer may need more frequent testing to watch for recurrence. The exact schedule is decided by your oncologist based on your stage, treatment, and response.

The CA 15.3 test mainly relates to breast cancer, helping with monitoring rather than diagnosis. A raised level may be associated with:

The CA 15.3 test needs no special preparation, which makes it simple and convenient.

What to Expect Before the Test

• No fasting is required. You can eat and drink normally beforehand.
• If the test is combined with other tests that need fasting, follow those specific instructions.
• Tell your doctor about your treatment, medicines, and any other conditions, as these help with result interpretation.
• For monitoring, it helps to use the same lab over time so results are directly comparable.

What to Expect During the Blood Collection

A phlebotomist cleans the skin with an antiseptic, then places an elastic band around your upper arm to make the veins easier to access. A small needle is inserted into the vein; you may feel a brief pinch. Blood is collected into a labelled tube in under a minute.

What to Expect After the Test

A small cotton swab and bandage are placed over the site to stop any minor bleeding. There may be slight soreness at the needle site or mild light-headedness. If you feel dizzy, sit and rest for a few minutes.

The CA 15.3 Test measures a single parameter - the level of cancer antigen 15-3 (MUC-1) in the blood, reported in units per millilitre (U/mL).

• Cancer antigen 15-3 (CA 15-3 / MUC-1) - a protein shed by breast tumour cells. A higher level can reflect active or advanced breast cancer, while a falling level over time can reflect a good response to treatment.

Because no single marker is perfect, your doctor interprets CA 15-3 together with your clinical examination, imaging, and sometimes other markers to make decisions about your care.

The CA 15.3 Test measures a single parameter - the level of cancer antigen 15-3 (MUC-1) in the blood, reported in units per millilitre (U/mL).

• Cancer antigen 15-3 (CA 15-3 / MUC-1) - a protein shed by breast tumour cells. A higher level can reflect active or advanced breast cancer, while a falling level over time can reflect a good response to treatment.

Because no single marker is perfect, your doctor interprets CA 15-3 together with your clinical examination, imaging, and sometimes other markers to make decisions about your care.

CA 15-3 results are best understood as a trend over time rather than a single number, and always in the context of your overall care.

Several non-cancer conditions and other cancers can cause a raised (false-positive) CA 15-3, which is why the result is never used alone. Your oncologist combines it with examination, scans, and other tests before drawing conclusions.

Disclaimer: This information is for educational purposes and provides a risk assessment only. It does not confirm a diagnosis. Always consult your doctor to understand how your CA 15-3 result relates to your overall health.

The CA 15.3 test is a routine blood draw that is generally very safe, with minor procedural risks and some important limitations.

Potential Risks and Complications

Most people feel only a brief pinch. Consult your doctor if you notice:

• dedness that continues after the blood draw. Sit and rest before leaving.

Understanding CA 15.3 Test Limitations

• It is not a screening or diagnostic test, it cannot be used to diagnose breast cancer on its own.
• Not all breast cancers raise CA 15-3, so a normal level does not exclude cancer.
• Other cancers and benign conditions can raise the level, causing false-positive results.
• Values differ between testing methods, so trends should be tracked using the same lab and method.

CA 15-3 is rarely used alone. Your doctor may order additional tests to complete the assessment.